| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Travere Therapeutics, Inc. | Director | Common Stock | 55,500 | $1,944,353 | $35.03 | 31 Oct 2025 | Direct |
| FATE THERAPEUTICS INC | Director | Stock Option (Right to Buy) | 40,000 | $109,200 | $2.73 | 07 Jun 2024 | Direct |
| aTYR PHARMA INC | Director | Common Stock | 56,000 | $98,000 | $1.75 | 30 May 2024 | Indirect |
| ADC Therapeutics SA | Director | Common Shares | 40,000 | $53,600 | $1.34 | 03 Jun 2025 | Direct |
| ADC Therapeutics SA | Director | Stock Options (Right to Buy) | 80,000 | 03 Jun 2025 | Direct | ||
| aTYR PHARMA INC | Director | Stock Option (right to buy) | 50,000 | 01 May 2025 | Direct | ||
| Travere Therapeutics, Inc. | Director | Stock option (right to buy) | 19,500 | 15 May 2025 | Direct | ||
| Travere Therapeutics, Inc. | Director | Director stock option (right to buy) | 0 | 31 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 31 Oct 2025 | 5 | -$325,561 | 4 | Director | 04 Nov 2025, 16:05 |
| ADCT | ADC Therapeutics SA | 03 Jun 2025 | 2 | $0 | 4 | Director | 05 Jun 2025, 17:13 |
| ADCT | ADC Therapeutics SA | 03 Jun 2025 | 0 | $0 | 3 | Director | 05 Jun 2025, 17:03 |
| TVTX | Travere Therapeutics, Inc. | 15 May 2025 | 2 | $0 | 4 | Director | 16 May 2025, 19:00 |
| ATYR | aTYR PHARMA INC | 01 May 2025 | 1 | $0 | 4 | Director | 02 May 2025, 17:16 |
| FATE | FATE THERAPEUTICS INC | 07 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 16:29 |
| ATYR | aTYR PHARMA INC | 30 May 2024 | 1 | +$87,500 | 4 | Director | 03 Jun 2024, 16:21 |
| ATYR | aTYR PHARMA INC | 22 May 2024 | 1 | $0 | 4 | Director | 23 May 2024, 19:07 |
| TVTX | Travere Therapeutics, Inc. | 08 May 2024 | 2 | $0 | 4 | Director | 10 May 2024, 16:05 |
| FATE | FATE THERAPEUTICS INC | 06 Jun 2023 | 1 | $0 | 4 | Director | 07 Jun 2023, 16:06 |
| ATYR | aTYR PHARMA INC | 17 May 2023 | 3 | $0 | 4 | Director | 19 May 2023, 16:27 |
| TVTX | Travere Therapeutics, Inc. | 17 May 2023 | 2 | $0 | 4 | Director | 19 May 2023, 16:05 |
| ATYR | aTYR PHARMA INC | 26 Apr 2023 | 2 | $0 | 4 | Director | 28 Apr 2023, 16:51 |
| FATE | FATE THERAPEUTICS INC | 09 Jun 2022 | 2 | $0 | 4 | Director | 13 Jun 2022, 16:39 |
| FATE | FATE THERAPEUTICS INC | 03 Jun 2022 | 1 | -$32,824 | 4 | Director | 06 Jun 2022, 16:43 |
| TVTX | Travere Therapeutics, Inc. | 11 May 2022 | 2 | $0 | 4 | Director | 12 May 2022, 20:22 |
| ATYR | aTYR PHARMA INC | 26 Apr 2022 | 1 | $0 | 4 | Director | 28 Apr 2022, 19:42 |
| FATE | FATE THERAPEUTICS INC | 02 Jun 2021 | 2 | $0 | 4 | Director | 04 Jun 2021, 17:33 |
| TVTX | Travere Therapeutics, Inc. | 14 May 2021 | 2 | $0 | 4 | Director | 18 May 2021, 21:30 |